non-invasive thigh laxity treatment post-glp-1 therapy Prevent and address sagging skin from age or GLP-1 weight loss with this simple, expert-approved approach Noticing “Ozempic face” or loose

Lean mass preservation is now treated as an active therapeutic priority in GLP-1 care, not a secondary concern

The Muscle Mechanism On the muscle side, photobiomodulations primary target is cytochrome c oxidase the terminal enzyme in the mitochondrial electron transport chain

Waiting ensures: More predictable, longer-lasting results Reduced risk of needing revision surgery due to ongoing weight changes Most patients are advised to maintain a stable weight for several months before proceeding with body contouring, facial surgery, or breast procedures

Muscle Loss Associated with GLP-1 Usage Scientific studies show that GLP-1 medications can reduce both fat and lean muscle mass

Red light reaches the dermis where fibroblasts produce collagen

Aspiration Risk and Preoperative Preparation Delayed gastric emptying from GLP-1 medications increases aspiration risk during anesthesia, even with appropriate fasting